Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders
AstraZeneca's pain is resulting in a big gain for Pfizer and BioNTech.
Full Article
Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders
Motley Fool
0 shares
1 views
You might like
Related news coverage
FTSE 100 firmly in the red; Wall Street opens on a mixed footing
FTSE 100 down 33 points COVID-19 infections fell by 65% after first dose of vaccine US stocks see mixed open 2.42pm: Mixed start..
Proactive Investors
FTSE 100 firmly in the red; COVID-19 infections fall significantly after single dose vaccines are rolled out, study shows
FTSE 100 down 41 points COVID-19 infections fell by 65% after first dose of vaccine Bitcoin drops below US$50,000 1.30pm: COVID-19..
Proactive Investors